AstraZeneca Can't Shed FCA Suit Over Seroquel 'Scheme'
By Jeff Overley · April 18, 2017, 5:23 PM EDT
A New York federal judge on Monday preserved a whistleblower's False Claims Act suit accusing AstraZeneca PLC of concealing safety information about antipsychotic drug Seroquel, finding plausible allegations of a "complex...
To view the full article, register now.